Review3 Biotech2024
Natural biosynthesis, pharmacological applications, and sustainable biotechnological production of ornamental plant-derived anthocyanin: beyond colorants and aesthetics.
Review in 3 Biotech, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Transcriptomic Insights into Anthocyanin Biosynthesis inInternational journal of molecular sciences · 2025Article
- Biosynthesis and Extraction of Chlorophyll, Carotenoids, Anthocyanins, and Betalaine In Vivo and In Vitro.Current issues in molecular biology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Flowers have long been admired for their aesthetic qualities and have even found their way to be included in the human diet. Among the many chemical compounds found in flowers, anthocyanins stand out for their versatile applications in the food, cosmetic, and nutraceutical industries. The biosynthetic pathway of anthocyanins has been thoroughly studied in certain flower species, leading to the detection of key regulatory genes that can be controlled to enhance the production of anthocyanins via biotechnological methods. Nevertheless, the quantity and form of anthocyanins found in natural sources differ, both qualitatively and quantitatively, depending on the ornamental plant species. For this reason, research on in vitro plant cultures has been conducted for years in an attempt to comprehend how these essential substances are produced. Different biotechnological systems, like in vitro plant cell, organ, and tissue cultures, and transgenic approaches, have been employed to produce anthocyanins under controlled conditions. However, multiple factors influence the production of anthocyanins and create challenges during large-scale production. Metabolic engineering techniques have also been utilized for anthocyanin production in microorganisms and recombinant plants. Although these techniques are primarily tested at lab- and pilot-scale, limited studies have focused on scaling up the production. This review analyses the chemistry and biosynthesis of anthocyanin along with the factors that influence the biosynthetic pathway. Further emphasis has been given on strategies for conventional and non-conventional anthocyanin production along with their quantification, addressing the prevailing challenges, and exploring ways to ameliorate the production using the in vitro plant cell and tissue culture systems and metabolic engineering to open up new possibilities for the cosmetic, pharmaceutical, and food industries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.